A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index; 7 of the 23 sources its claims cite were checked for support.
Abstract
PURPOSE: We introduce two validated single (SH) and dual hormone (DH) mathematical models that represent an in-silico virtual patient population (VPP) for type 1 diabetes (T1D). The VPP can be used to evaluate automated insulin and glucagon delivery algorithms, so-called artificial pancreas (AP) algorithms that are currently being used to help people with T1D better manage their glucose levels. We present validation results comparing these virtual patients with true clinical patients undergoing AP control and demonstrate that the virtual patients behave similarly to people with T1D. METHODS: A single hormone virtual patient population (SH-VPP) was created that is comprised of eight differential equations that describe insulin kinetics, insulin dynamics and carbohydrate absorption. The parameters in this model that represent insulin sensitivity were statistically sampled from a normal distribution to create a population of virtual patients with different levels of insulin sensitivity. A dual hormone virtual patient population (DH-VPP) extended this SH-VPP by incorporating additional equations to represent glucagon kinetics and glucagon dynamics. The DH-VPP is comprised of thirteen differential equations and a parameter representing glucagon sensitivity, which was statistically sampled from a normal distribution to create virtual patients with different levels of glucagon sensitivity. We evaluated the SH-VPP and DH-VPP on a clinical data set of 20 people with T1D who participated in a 3.5-day outpatient AP study. Twenty virtual patients were matched with the 20 clinical patients by total daily insulin requirements and body weight. The identical meals given during the AP study were given to the virtual patients and the identical AP control algorithm that was used to control the glucose of the virtual patients was used on the clinical patients. We compared percent time in target range (70-180 mg/dL), time in hypoglycemia (<70 mg/dL) and time in hyperglycemia (>180 mg/dL) for both the virtual patients and the actual patients. RESULTS: The subjects in the SH-VPP performed similarly vs. the actual patients (time in range: 78.1 ± 5.1% vs. 74.3 ± 8.1%, p = 0.11; time in hypoglycemia: 3.4 ± 1.3% vs. 2.8 ± 1.7%, p = 0.23). The subjects in the DH-VPP also performed similarly vs. the actual patients (time in range: 75.6 ± 5.5% vs. 71.9 ± 10.9%, p = 0.13; time in hypoglycemia: 0.9 ± 0.8% vs. 1.3 ± 1%, p = 0.19). While the VPPs tended to over-estimate the time in range relative to actual patients, the difference was not statistically significant. CONCLUSIONS: We have verified that a SH-VPP and a DH-VPP performed comparably with actual patients undergoing AP control using an identical control algorithm. The SH-VPP and DH-VPP may be used as a simulator for pre-evaluation of T1D control algorithms.
Overview
CoChat Summary
TL;DR
The paper presents single-hormone and dual-hormone virtual patient populations for type 1 diabetes, built from glucoregulatory models with statistically sampled insulin and glucagon sensitivity parameters and an integrated aerobic exercise model. When matched to 20 clinical patients by total daily insulin requirement and weight and run under identical meals and the same artificial pancreas controller, the virtual populations showed no statistically significant differences in key glycemic outcomes.
Key findings
- The single-hormone VPP performed similarly to actual patients: time in range 78.1 ± 5.1% vs. 74.3 ± 8.1% (p = 0.11), and time in hypoglycemia 3.4 ± 1.3% vs. 2.8 ± 1.7% (p = 0.23).
- The dual-hormone VPP also performed similarly to actual patients: time in range 75.6 ± 5.5% vs. 71.9 ± 10.9% (p = 0.13), and time in hypoglycemia 0.9 ± 0.8% vs. 1.3 ± 1% (p = 0.19).
- Time in hyperglycemia was not significantly different for SH-VPP (18.4 ± 5.3% vs. 22.9 ± 8.8%, p = 0.08) or DH-VPP (23.5 ± 5.7% vs. 26.7 ± 11.4%, p = 0.21).
- In a comparison across 10 selected meal scenarios, the SH-VPP had lower mean absolute error for time in range relative to clinical data than the UVA/Padova simulator (15.8% vs. 33.4%).
Methods
- The SH-VPP used eight differential equations for insulin kinetics, insulin dynamics, and carbohydrate absorption; the DH-VPP extended this to thirteen equations by adding glucagon kinetics and dynamics. Insulin sensitivity factors (Sf1, Sf2, Sf3) were statistically sampled for the SH-VPP; glucagon sensitivity and related parameters were also sampled for the DH-VPP.
- Validation used clinical data from 20 people with T1D in two separate 3.5-day randomized outpatient artificial pancreas trials, with meals, daily activities, and in-clinic aerobic exercise at 60% of maximal VO2. Twenty virtual patients were matched to the 20 clinical patients by closest total daily insulin requirement and weight.
- The identical meals and the same OHSU-FMPD control algorithm were applied to virtual patients, with ±30% meal uncertainty, circadian insulin sensitivity variability, and CGM noise modeled. Outcomes were compared using two-tailed t-tests at a 5% significance level, with mean absolute error reported.
Limitations
- The paper states that meal amount was estimated rather than known, rescue carbohydrate timing was uncertain, circadian insulin sensitivity variability was modeled approximately, the exercise model assumed 50% active muscular mass for all subjects, and CGM noise was based on the Dexcom G4 sensor while clinical data used the Dexcom G5.
- The paper states that mean absolute error was higher than preferred for time in range and time in hyperglycemia, indicating imperfect individual-level matching.
- Evident from the text: validation used only one control algorithm and a relatively small clinical sample of 20 patients, so generalizability to other controllers or larger populations is not directly established.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
6 Valid · 2 Not valid · 11 Not checked · 40 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“These virtual populations were validated against clinical data acquired from real-world patients with T1D [12].”
§ A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model > Discussion and conclusion
What the sources say
- Could not verifycites [12] Castle JR, El Youssef J, Wilson LM, Reddy R, Resalat N, Branigan D, et al Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors. Diabetes care. 2018 Epub 2018/05/13. 10.2337/dc18-0228. 29752345 PMC6014543 sourceExperimental — accuracy not yet measured
The Participants and Study Design and Procedures sections describe a trial involving adults with type 1 diabetes, not two virtual patient populations. A search for virtual populations, simulation, and validation against clinical data found no passage addressing the claimed validation. (LLM, conf=0.75)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“Since insulin is known to vary during the day [24], circadian variability of insulin sensitivity was introduced to the insulin sensitivity parameters (Sf1, Sf2 and Sf3) within each virtual patient by varying these parameters with respect to time of day using Eq (12):”
- Also stated in: § Discussion and conclusion · plain
“Third, it is known that insulin sensitivity can vary throughout the day.”
§ A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model > Materials and methods > Validating VPPs under real-world meal scenarios
What the sources say
- Supportedcites [24] Herrero P, Bondia J, Adewuyi O, Pesl P, El-Sharkawy M, Reddy M, et al Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator—in silico evaluation under intra-day variability. Computer methods and programs in biomedicine. 2017; 146: 125– 31. Epub 2017/07/10. 10.1016/j.cmpb.2017.05.010. 28688482 PMC6522376 source
In Materials and Methods, under “Intra-day variability,” the paper says insulin sensitivity parameters were assumed to vary throughout the day in a sinusoidal pattern. This supports the attributed point that insulin sensitivity varies with time of day, though the passage describes an assumption used in the simulation. (LLM, conf=0.89)
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Discussion and conclusion · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For all outcome measures, the SH-VPP was not statistically different than the true population.”
§ A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The MAE of time spent in hyperglycemia was high for SH-VPP showing that the meal model should be further improved to better represent glucose levels above 180 mg/dl.”
§ A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model > Results
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, they misestimated the time in hypoglycemia compared to the clinical data.”
§ A statistical virtual patient population for the glucoregulatory system in type 1 diabetes with integrated exercise model > Discussion and conclusion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
30 more claims
Create a free account to see all 59 claims and to verify the 2 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 9
- The quote only partly states this claim. 1
Citations
Cites
Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes
Hovorka, R., Canonico, V., Chassin, L. J., Haueter, U., Massi-Benedetti, M., Federici, M. O., Pieber, T. R., Schaller, H. C., Schaupp, L., Vering, T., et al. (2004) · Physiological Measurement · doi:10.1088/0967-3334/25/4/010 · Cited by 1,274
Exercise management in type 1 diabetes: a consensus statement
Riddell, M. C., Gallen, I. W., Smart, C. E., Taplin, C. E., Adolfsson, P., Lumb, A. N., Kowalski, A., Rabasa-Lhoret, R., McCrimmon, R. J., Hume, C., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30014-1 · Cited by 903
The UVA/PADOVA Type 1 Diabetes Simulator: New Features
Man, C. D., Micheletto, F., Lv, D., Breton, M., Kovatchev, B., & Cobelli, C. (2014) · Journal of Diabetes Science and Technology · doi:10.1177/1932296813514502 · Cited by 791
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes
Kovatchev, B. P., Breton, M., Dalla Man, C., & Cobelli, C. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300106 · Cited by 760
Simulation Environment to Evaluate Closed-Loop Insulin Delivery Systems in Type 1 Diabetes
Wilinska, M. E., Chassin, L. J., Acerini, C. L., Allen, J. M., Dunger, D. B., & Hovorka, R. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400117 · Cited by 244
Castle, J. R., El Youssef, J., Wilson, L. M., Reddy, R., Resalat, N., Branigan, D., Ramsey, K., Leitschuh, J., Rajhbeharrysingh, U., Senf, B., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0228 · Cited by 152
Self-citationModeling the glucose sensor error
Facchinetti, A., Del Favero, S., Sparacino, G., Castle, J. R., Ward, W. K., & Cobelli, C. (2014) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2013.2284023 · Cited by 130
Jacobs, P. G., El Youssef, J., Reddy, R., Resalat, N., Branigan, D., Condon, J., Preiser, N., Ramsey, K., Jones, M., Edwards, C., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12707 · Cited by 116
Self-citationJacobs, P. G., Resalat, N., El Youssef, J., Reddy, R., Branigan, D., Preiser, N., Condon, J., & Castle, J. (2015) · Journal of Diabetes Science and Technology · doi:10.1177/1932296815609371 · Cited by 105
Self-citationWalsh, J., Roberts, R., & Bailey, T. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400516 · Cited by 103
Cited by
Diagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
“The hyperglycemia or hypoglycemia causes identification performed through validated single and dual hormone mathematical models that demonstrate a virtual platform of T1D patients [109].”
BackgroundAn artificial intelligence decision support system for the management of type 1 diabetes
Tyler, N. S., Mosquera-Lopez, C. M., Wilson, L. M., Dodier, R. H., Branigan, D. L., Gabo, V. B., Guillot, F. H., Hilts, W. W., El Youssef, J., Castle, J. R., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0212-y · Cited by 163
Self-citationEnvisioning the Future of Personalized Medicine: Role and Realities of Digital Twins
Vallée, A. (2024) · Journal of Medical Internet Research · doi:10.2196/50204 · Cited by 201
“In a similar vein, endeavors have been made to craft digital patients with precise measurements, such as glucose levels, either through mathematical models [62] or by incorporating highly specific attributes [81].”
BackgroundJacobs, P. G., Herrero, P., Facchinetti, A., Vehi, J., Kovatchev, B., Breton, M. D., Cinar, A., Nikita, K. S., Doyle, F. J., Bondia, J., et al. (2024) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2023.3331297 · Cited by 113
Self-citationArtificial Intelligence in Decision Support Systems for Type 1 Diabetes
Tyler, N. S., & Jacobs, P. G. (2020) · Sensors · doi:10.3390/s20113214 · Cited by 93
“While these dynamic models can be used to forecast glycemic outcomes [15,26,27], many of these physical models have been developed to simulate the glucose dynamics of T1D populations [28,29] and to design and evaluate DSS algorithms [19].”
MethodSelf-citationDigital twins and artificial intelligence in metabolic disease research
MOSQUERA-LOPEZ, C. M., & Jacobs, P. G. (2024) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2024.04.019 · Cited by 98
Self-citationDigital twins in healthcare: a comprehensive review and future directions
Rudsari, H. K., Tseng, B., Zhu, H., Song, L., Gu, C., Roy, A., Irajizad, E., Butner, J. D., Long, J. P., & Do, K.-A. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1633539 · Cited by 152
Wilson, L. M., Jacobs, P. G., Ramsey, K., Resalat, N., Reddy, R. K. K., Branigan, D. L., LEITSCHUH, J. A., Gabo, V. B., Guillot, F. H., Senf, B., et al. (2020) · Diabetes Care · doi:10.2337/dc19-2267 · Cited by 64
Self-citationMOSQUERA-LOPEZ, C. M., Wilson, L. M., Youssef, J. E., Hilts, W. W., LEITSCHUH, J. A., Branigan, D. L., Gabo, V. B., Eom, J. H., Castle, J. R., & Jacobs, P. G. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00783-1 · Cited by 73
“All data collected during the study including glucose sensor data, insulin data, physical activity data, and meal data, were aggregated in real time by the OHSU iPancreas app and stored for remote monitoring and further analysis on a cloud-based database hosted on an OHSU-managed secure server called iPancreas Guidanc…”
MethodInfluentialSelf-citationMOSQUERA-LOPEZ, C. M., Dodier, R. H., Tyler, N. S., Wilson, L. M., Youssef, J. E., Castle, J. R., & Jacobs, P. G. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0458 · Cited by 54
“Each virtual patient had a different insulin sensitivity that was statistically sampled from a distribution as described further in Resalat et al.(37) Twenty real-world meal scenarios acquired from people with T1D during a 4-day outpatient study(23) were given to these virtual patients and insulin dosing problems were…”
MethodInfluentialSelf-citationJacobs, P. G., Resalat, N., Hilts, W., Young, G. M., Leitschuh, J., Pinsonault, J., El Youssef, J., Branigan, D., Gabo, V., Eom, J., et al. (2023) · The Lancet Digital Health · doi:10.1016/s2589-7500(23)00112-7 · Cited by 37
Self-citationResalat, N., Hilts, W. W., Youssef, J. E., Tyler, N. S., Castle, J. R., & Jacobs, P. G. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819881467 · Cited by 42
“We have previously described how we incorporate an exercise model into the MPC.(10,25) This is briefly described in the Supplemental Material.”
MethodInfluentialSelf-citationSanz, R., García, P., Díez, J.-L., & Bondía, J. (2020) · IEEE Transactions on Control Systems Technology · doi:10.1109/tcst.2020.2975147 · Cited by 42
“The scenario also takes into account the large intrasubject variability by varying insulin absorption model parameters up to ±30% from one meal intake to another and insulin sensitivity parameters up to ±30% with a sinusoidal pattern along the day [50].”
BackgroundDigital Twins in Type 1 Diabetes: A Systematic Review
Cappon, G., & Facchinetti, A. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241262112 · Cited by 44
“…a Maximum Likelihood (least squares) regression approach, 16,25,29 whereas the method of Young et al 33 twinned each patient by simply matching him/her to the virtual patient of an existing virtual population 32 who exhibits the most similar glucose trace in a specific before-exercise time window.”
InfluentialZhu, T., Li, K., & Georgiou, P. (2023) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2023.3303367 · Cited by 50
“It is noted that recent T1D simulators have incorporated physical activities and exercise [70], [71].”
Design and In Silico Evaluation of an Exercise Decision Support System Using Digital Twin Models
Young, G. M., Dodier, R. H., Youssef, J. E., Castle, J. R., Wilson, L. M., Riddell, M. C., & Jacobs, P. G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231223217 · Cited by 30
“27,28 Data-driven digital twins have been used in combination with coaching and medication interventions to help reduce HbA1c in people with type 2 diabetes.”
BackgroundMethodSelf-citationViroonluecha, P., Egea-López, E., & Santa, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0274608 · Cited by 31
Hettiarachchi, C., Malagutti, N., Nolan, C. J., Suominen, H., & Daskalaki, E. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2023.105839 · Cited by 36
Modelling glucose dynamics during moderate exercise in individuals with type 1 diabetes
Alkhateeb, H., Fathi, A. E., Ghanbari, M., & Haidar, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248280 · Cited by 23
“[25] incorporated Hernandez’s model into a model of single- and dual-hormone virtual patient population.”
MethodDeichmann, J., Bachmann, S., Burckhardt, M., Pfister, M., Szinnai, G., & Kaltenbach, H. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010289 · Cited by 25
“Other models have been proposed [23–26] and a virtual patient population has been generated [27] that incorporates PA [24].”
A physical activity-intensity driven glycemic model for type 1 diabetes
Hobbs, N., Samadi, S., Rashid, M. M., Shahidehpour, A., Askari, M. R., Park, M., Quinn, L., & Çınar, A. (2022) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2022.107153 · Cited by 19
Resalat, N., Youssef, J. E., Reddy, R. K. K., Castle, J. R., & Jacobs, P. G. (2019) · Journal of Process Control · doi:10.1016/j.jprocont.2019.05.018 · Cited by 20
Self-citationMOSQUERA-LOPEZ, C. M., Roquemen-Echeverri, V., Tyler, N. S., Patton, S. R., Clements, M. A., Martin, C. K., Riddell, M. C., Gal, R. L., Gillingham, M. B., Wilson, L. M., et al. (2023) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocad196 · Cited by 23
Self-citationEstremera, E., Cabrera, A., Beneyto, A., & Vehí, J. (2022) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2022.104141 · Cited by 22
Pleouras, D. S., Sakellarios, A. I., Rigas, G., et al. (2021) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2021.3082328 · Cited by 14
“, glucose measurements) using mathematical models [24] or using very specific features [25] (non-demographics).”
MethodSun, X., Rashid, M. M., Hobbs, N., Askari, M. R., Brandt, R., Shahidehpour, A., & Çınar, A. (2021) · Control Engineering Practice · doi:10.1016/j.conengprac.2021.104933 · Cited by 16
Cai, D., Wu, W., Cescon, M., Liu, W., Ji, L., & Shi, D. (2023) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2023.100897 · Cited by 15
Aaron, R. E., Tian, T., Yeung, A. M., Huang, J. K., Arreaza-Rubín, G., Ginsberg, B. H., Kompala, T., Lee, W.-A., Kerr, D. E., Colmegna, P. H., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231201829 · Cited by 14
“14 The model was evaluated on real-world data from the T1D in exercise initiative data set (T1Dexi).”
MethodYoussif, K. A., Elshamy, A. M., Rabeh, M. A., et al. (2020) · ChemistrySelect · doi:10.1002/slct.202002947 · Cited by 13
Generation of Virtual Patient Populations That Represent Real Type 1 Diabetes Cohorts
Ahmad, S., Ramkissoon, C. M., Beneyto, A., Conget, I., Giménez, M., & Vehí, J. (2021) · Mathematics · doi:10.3390/math9111200 · Cited by 15
“The most well-known simulators used in AP research are the University of Virginia/Padova (UVa/Padova) simulator [3], Oregon Health and Science University (OHSU) simulator [4], and Cambridge Simulator [5].”
MethodGrosman, B., Parikh, N., Roy, A., LINTEREUR, L. J., Vigersky, R. A., Cohen, O., & Rhinehart, A. S. (2022) · Annals of Biomedical Engineering · doi:10.1007/s10439-022-03079-9 · Cited by 13
Integrating Multiple Inputs Into an Artificial Pancreas System: Narrative Literature Review
Hettiarachchi, C., Daskalaki, E., Desborough, J., Nolan, C. J., O'Neal, D. N., & Suominen, H. (2022) · JMIR Diabetes · doi:10.2196/28861 · Cited by 14
“Resalat et al [43] developed a run-to-run MPC that used continuous MET data for exercise detection.”
BackgroundMethodInfluentialDetection of physical activity using machine learning methods
Dénes-Fazakas, L., Szilagyi, L., Tasic, J., Kovács, L., & Eigner, G. (2020) · IEEE International Symposium on Computational Intelligence and Informatics (CINTI) · doi:10.1109/cinti51262.2020.9305845 · Cited by 14
“In this study, we apply synthetic data generated by an extended version of the Jacobs T1DM simulator [17].”
MethodRecent advancements and applications of physics-informed machine learning in biomedical research
Roquemen-Echeverri, V., & MOSQUERA-LOPEZ, C. M. (2025) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2025.100612 · Cited by 11
Villa-Tamayo, M. F., Colmegna, P. H., & Breton, M. D. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0595 · Cited by 11
“Other well-known platforms include the Oregon Health and Science University simulator, 5 and the Cambridge simulator.”
Palumbo, M. C., de Graaf, A. A., Morettini, M., Tieri, P., Krishnan, S., & Castiglione, F. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107158 · Cited by 10
Evaluation of Offline Reinforcement Learning for Blood Glucose Level Control in Type 1 Diabetes
Viroonluecha, P., Egea-López, E., & Santa, J. (2023) · IEEE Access · doi:10.1109/access.2023.3318324 · Cited by 10
“AIDA is a free software simulating human plasma insulin and blood glucose for education and research purposes.”
MethodYoung, G. M., Jacobs, P. G., Tyler, N. S., Nguyen, T.-T. P., Castle, J. R., Wilson, L. M., Branigan, D. L., Gabo, V. B., Guillot, F. H., Riddell, M. C., et al. (2023) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00298.2022 · Cited by 9
Self-citationEstremera, E., Beneyto, A., Cabrera, A., Contreras, I., & Vehí, J. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107568 · Cited by 9
Diabetes Technology Meeting 2020
Shang, T., Zhang, J. Y., Bequette, B. W., Raymond, J. K., Coté, G. L., Sherr, J. L., Castle, J. R., Pickup, J. C., Pavlovic, Y., Espinoza, J., et al. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211016480 · Cited by 9
Self-citationDynamic of Glucose Homeostasis in Virtual Patients: A Comparison between Different Behaviors
Alonso‐Bastida, A., Adam‐Medina, M., Posada, R., Salazar-Piña, D. A., Osorio-Gordillo, G. L., & Valdés, L. G. V. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19020716 · Cited by 6
Furió-Novejarque, C., Sanz, R., Ritschel, T. K. S., Reenberg, A. T., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106605 · Cited by 7
Reinforcement Learning for Multiple Daily Injection (MDI) Therapy in Type 1 Diabetes (T1D)
Jaloli, M., & Cescon, M. (2023) · BioMedInformatics · doi:10.3390/biomedinformatics3020028 · Cited by 8
“[30] proposed a k-nearest-neighbors (KNN)-based decision support system to provide weekly insulin dose recommendations, including basal, correction factor (CF), or carbohydrate ratio (CR) modification, using data obtained from a simulator established in [31].”
MethodMetabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.18800.ac · Cited by 5
Self-citationVirtual therapy using Type 1 Diabetes Direct Simulator
Nowicki, T. J. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1736/1/012031 · Cited by 4
“It should be noted here that other alternative models are also being developed for example: Single / Dual Hormone Virtual Patient Population [14] or Multivariable Integrated Metabolic & Physiologic Simulator [15].”
MethodAssessment of a new model of glucagon action with glucagon receptor dynamics
Furió-Novejarque, C., Sanz, R., Reenberg, A. T., Ritschel, T. K. S., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2022) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2022.09.169 · Cited by 5
Method to generate a large cohort in-silico for type 1 diabetes
Orozco-López, O., Rodríguez-Herrero, A., Castaneda, C. E., García-Sáez, G., & Hernando, M. E. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105523 · Cited by 7
Deichmann, J., & Kaltenbach, H. (2023) · Journal of Process Control · doi:10.1016/j.jprocont.2023.103042 · Cited by 7
Metabolic Models, in Silico Trials, and Algorithms
Çınar, A., Basu, A., Bequette, B. W., Breton, M. D., Buckingham, B. A., Cengiz, E., Cobelli, C., Dassau, E., Doyle, F. J., Fabris, C., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251338300 · Cited by 10
Self-citationRoquemen-Echeverri, V., Kushner, T., Jacobs, P. G., & MOSQUERA-LOPEZ, C. M. (2026) · Neural Computing and Applications · doi:10.1007/s00521-026-12018-x · Cited by 10
“Thus, we prioritized comparisons between our proposed methodology and the clinically validated ODE-based glucoregulatory model developed by Resalat et al. [12], as follows: • ODE-based population-level model: We simulated real-world scenarios using the population model parameters presented in [12].”
InfluentialSelf-citationScharbarg, E., Greck, J., Carpentier, É. L., Chaillous, L., & Moog, C. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-11772-x · Cited by 4
Deichmann, J., Bachmann, S., Pfister, M., Szinnai, G., & Kaltenbach, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.09.447693 · Cited by 3
“Based on the latter, a virtual patient population generator capturing PA has been proposed [36].”
BackgroundStipanicic, A., Couture, G., Rivest, C., Rousseau, M., & Paquette, M. (2021) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2021.10.018 · Cited by 4
Blood Glucose Regulation Models in Artificial Pancreas for Type-1 Diabetic Patients
Chandrasekhar, A., & Padhi, R. (2023) · Journal of the Indian Institute of Science · doi:10.1007/s41745-023-00362-z · Cited by 3
Virtual diabetic patient with physical activity dynamics
Islam, M. J., & Hoque, A. S. M. L. (2021) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2021.106485 · Cited by 3
Virtual Patients: An Enabling Technology for Multivariable Control of Biomedical Systems
Rashid, M. M., Samadi, S., Sevil, M., Hobbs, N., Park, M., Quinn, L., & Çınar, A. (2020) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2020.12.616 · Cited by 2
A Minimal Model for Type-1 DM Patients: Meal and Exercise Adaptation
Chandrasekhar, A., & Padhi, R. (2024) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2024.05.009 · Cited by 1
Kushner, T., MOSQUERA-LOPEZ, C. M., Hilts, W. W., LEITSCHUH, J. A., Dodier, R. H., Branigan, D. L., Eom, J. H., Howard, M., Aby-Daniel, D., Wilson, L. M., et al. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968251386058 · Cited by 2
“Using the OHSU T1D simulator, 18 we evaluated the performance of an exercise-aware model predictive control algo-rithm 19 (exMPC) with automated meal detection and correction dosing either under typical operation (baseline) or alternatively with use of the BlockRQA correction dosing (BlockRQA +…”
Self-citationGlucose Predictions Improve Glycemic Control: A Digital Twin Evaluation
Herrero, P., Andorrà, M., Breton, M. D., Peak, A., Koehler, M., Klopfenstein, Y., Leppäaho, E., Zanon, M., Ringemann, C., Lustenberger, P., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261432144 · Cited by 6
“12 While these platforms effectively model population-level physiological diversity, they are less adept at capturing the high intrasubject variability observed in real-world settings.”
Glucose Regulation Using an Intelligent PID Controller
Willmon, P. A. (2020) · Cited by 1
Deichmann, J., Bachmann, S., Burckhardt, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.10.495592 · Cited by 1
Viroonluecha, P. (2023) · Digital Repository (Polytechnic University of Cartagena) · doi:10.31428/10317/12437 · Cited by 1
Replicate Engineered Virtual Patient Populations as Surrogates for Real Patient-Level DataPreprint
Alenghat, F. J. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/308403
A Multi-Scale Immune System Simulator for the Onset of Type 2 Diabetes
Palumbo, M. C., & Castiglione, F. (2023) · SEMA SIMAI Springer series · doi:10.1007/978-3-031-35715-2_6
Transformed by the journey: building community with diverse fathers of people with autism
Hannon, M. D., & Naseef, R. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85031-5.00027-x
Analysis on the contribution of glucagon receptors to glucose dynamics in type 1 diabetes
Furió-Novejarque, C., Sala-Mira, I., Ranjan, A. G., Nørgaard, K., Díez, J.-L., Jørgensen, J. B., & Bondía, J. (2024) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2024.100272
Artificial Intelligence in Automated Hormone Delivery
Jacobs, P. G., & MOSQUERA-LOPEZ, C. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13244-5.00017-1
Self-citationAmor, H., & Salim, A. (2024) · International Conference on Electrical Engineering and Automatic Control (ICEEAC) · doi:10.1109/iceeac61226.2024.10576254
“Also for VPP patients, the same scenario is applied, each patient received a meal consisting of 30g of carbohydrates at time t=50 min, followed by 70g at t=550 min, then 50g at t=1000 min, where the accompanied boluses are given in [18].”
MethodGLP-1 Receptor Agonists Models for Type 1 Diabetes: A Narrative Review
Furió-Novejarque, C., Díez, J.-L., & Bondía, J. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241285925 · Cited by 3
Bertachi, A. H., Biagi, L., Contreras, I., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5123906
On a Benchmark Problem for Automated Insulin Delivery in Type 1 Diabetes
Naik, V. V., Escorihuela‐Altaba, C., & Garcia‐Tirado, J. (2025) · Advances in industrial control · doi:10.1007/978-3-031-76312-0_7
In silico evaluation of pramlintide dosing algorithms in artificial pancreas systems
Torres, B. P., Sala-Mira, I., Furió-Novejarque, C., Sanz, R., García, P., Díez, J.-L., & Bondía, J. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110447
“…simulators exist for developing insulin-alone or even insulin-glucagon controllers, for instance, the UVA/Padova simulator, which received the Food and Drug Administration approval to be a substitute for preclinical trials with animals [17], the Cambridge simulator [15], or the OHSU simulator [18].”
An AI-enabled dual-hormone model predictive control algorithm that delivers insulin and pramlintide
Jacobs, P. G., Hilts, W. W., Dodier, R. H., LEITSCHUH, J. A., Eom, J. H., Branigan, D. L., Ling, F., Howard, M., MOSQUERA-LOPEZ, C. M., & Wilson, L. M. (2025) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2025.06.011
Self-citationAnalysis of commonly used meal models for type 1 diabetes from an identification perspective
Clara, F.-N., Sala-Mira, I., José-Luis, D., & Bondía, J. (2025) · IFAC-PapersOnLine · doi:10.1016/j.ifacol.2025.06.017
Model based analytical approach for physical activity quantification in people with type 1 diabetes
Jurao, F. L. D. R., Fushimi, E., & Garelli, F. (2025) · Medical & Biological Engineering & Computing · doi:10.1007/s11517-025-03467-y · Cited by 1
Bertachi, A. H., Biagi, L., Contreras, I., Estremera, E., Beneyto, A., & Vehí, J. (2025) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2025.101708
Enhanced Diabetes Management with Digital Twins: A Scoping Review (Preprint)Preprint
Cinar, B., van den Boom, L., & Maleshkova, M. (2026) · doi:10.2196/preprints.91729
Data, Process, and Data-Driven Representations of Digital Twins in Diabetes: Scoping Review
Cinar, B., van den Boom, L., & Maleshkova, M. (2026) · JMIR Diabetes · doi:10.2196/91729
Marchiori, H., Bonet, J., Galderisi, A., & Man, C. D. (2026) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2026.100450
Metadata
- Authors
- Resalat, N., El Youssef, J., Tyler, N., Castle, J., & Jacobs, P. G.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Jacobs, Peter G.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-07-25
- Volume
- 14
- Issue
- 7
- Pages
- e0217301
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6657828
- OpenAlex
- W2963898471
- Semantic Scholar
- 2ed50a04c433e06a870d929d0948c3de3cdeaebd
- Cited by
- 78
- References
- 28
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 10 · 2023: 19 · 2022: 8 · 2021: 11 · 2020: 10 · 2019: 2
- FWCI
- 6.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (1DP3DK101044)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- type 1 diabetes, virtual patient population, artificial pancreas, closed-loop glucose control, insulin kinetics, exercise model, insulin sensitivity, glucagon sensitivity, glucose homeostasis, time in range, hypoglycemia, hyperglycemia, carbohydrate absorption
- MeSH terms
- Adult, Aged, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glucagon, Humans, Insulin, Kinetics, Male, Middle Aged, Models, Biological
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.